Yes, DKA Can Occur in Type 2 Diabetes
Yes, patients with type 2 diabetes can absolutely develop diabetic ketoacidosis (DKA), though it occurs less frequently than in type 1 diabetes and typically requires specific precipitating factors. 1
When DKA Occurs in Type 2 Diabetes
DKA seldom occurs spontaneously in type 2 diabetes 1. The most recent ADA guidelines (2025) specify that when DKA does develop in type 2 diabetes, it typically occurs in these specific scenarios:
High-Risk Situations:
- Severe insulin deficiency in patients already on insulin therapy (missed or inadequate doses)
- Ketosis-prone type 2 diabetes (a distinct subtype)
- Acute illness stress: infection (particularly COVID-19), myocardial infarction, or other severe medical conditions
- Medication-induced: SGLT2 inhibitors, glucocorticoids, or second-generation antipsychotics 1
- Illicit drug use: particularly cocaine 1
- Social determinants of health affecting access to care or medications 1
Key Clinical Differences from Type 1 DKA
Type 2 diabetes patients who develop DKA present differently than type 1 patients 2, 3, 4:
Distinguishing Features:
- Longer symptom duration before presentation 3
- Higher body mass index and preserved insulin secretion capacity (higher C-peptide levels) 3
- More profound hyperglycemia: mean glucose levels around 48.4 mmol/L (872 mg/dL) versus 37.1 mmol/L (668 mg/dL) in type 1 4
- More severe dehydration requiring larger fluid volumes for resuscitation 4
Age-Related Patterns:
In elderly patients (≥65 years) with type 2 diabetes and DKA:
- More likely to develop DKA while already on diabetes treatment 3
- Lower BMI and impaired insulin secretion capacity 3
- Higher effective osmolarity 3
Critical SGLT2 Inhibitor Warning
SGLT2 inhibitors modestly but significantly increase DKA risk in type 2 diabetes, including euglycemic DKA (DKA with normal or near-normal glucose levels) 1, 5. This is particularly dangerous because:
- The normal glucose level can mask the diagnosis
- Risk increases 1.28-1.53 fold compared to other diabetes medications 5
- Must discontinue SGLT2 inhibitors 3-4 days before any surgery 6, 7
- High-risk scenarios include surgery, acute illness, prolonged fasting, or reduced oral intake 8, 6
Treatment Considerations
Type 2 diabetes patients with DKA require more aggressive treatment than type 1 patients 4:
- Higher insulin doses: approximately 35.9 units daily versus 20.2 units in type 1 4
- Larger fluid replacement volumes: 4.17 L versus 2.29 L 4
- Greater potassium supplementation: 23.9 mEq versus 11.2 mEq 4
Common Pitfall
The most dangerous misconception is that DKA "doesn't happen" in type 2 diabetes. While less common than in type 1, it absolutely occurs and carries significant mortality risk. The 2004 ADA guidelines note that both DKA and HHS can occur in both diabetes types 2. Healthcare providers must maintain high clinical suspicion, particularly in the presence of precipitating factors listed above.
Always check for ketones in any type 2 diabetes patient presenting with acute illness, nausea/vomiting, or unexplained metabolic acidosis, regardless of glucose level 9.